Medicinal Oxygen Air Liquide Sante

Country: European Union

Language: English

Source: EMA (European Medicines Agency)

Buy It Now

Active ingredient:

oxygen

Available from:

Air Liquide Santé International

ATC code:

QV03AN01

INN (International Name):

oxygen

Therapeutic group:

Horses; Dogs; Cats

Therapeutic area:

All other therapeutic products

Therapeutic indications:

For oxygen supplementation and as a carrier gas during inhalation anaesthesia.For oxygen supplementation during recovery.

Authorization status:

Withdrawn

Authorization date:

2006-12-20

Patient Information leaflet

                                Medicinal product no longer authorised
B. PACKAGE LEAFLET
12/15
Medicinal product no longer authorised
PACKAGE LEAFLET
Medicinal Oxygen Air Liquide Santé 100 % inhalation gas for dogs,
cats and horses.
1.
NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER AND OF
THE MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH
RELEASE, IF DIFFERENT
Marketing authorisation holder
:
AIR LIQUIDE Santé INTERNATIONAL
10, rue Cognacq-Jay
75341 Paris Cedex 07
FRANCE
Manufacturer for the batch release
:
AIR LIQUIDE Santé FRANCE
ZI Est, BP 34
54181 Heillecourt Cedex
FRANCE
2.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Medicinal Oxygen Air Liquide Santé 100 % inhalation gas for dogs,
cats and horses.
3.
STATEMENT OF THE ACTIVE SUBSTANCE(S) AND OTHER INGREDIENT(S)
Medicinal Oxygen Air Liquide Santé is an inhalation gas consisting of
100 % oxygen.
4.
INDICATION(S)
Medicinal Oxygen Air Liquide Santé can be used for oxygen
supplementation and as a carrier gas
during inhalation anaesthesia.
The veterinary medicinal product can also be used for oxygen
supplementation during recovery.
5.
CONTRAINDICATIONS
None.
6.
ADVERSE REACTIONS
None.
7.
TARGET SPECIES
Dogs, cats and horses.
13/15
Medicinal product no longer authorised
8.
DOSAGE FOR EACH SPECIES, ROUTE(S) AND METHOD OF ADMINISTRATION
The precise fresh gas flow rate required by an animal during
anaesthesia and recovery should be
determined by a suitably experienced veterinarian, taking into
consideration the bodyweight and health
status of the animal and the anaesthetic equipment and agents being
used. The animal must be
monitored closely, preferably by means of a pulse oximeter, and the
flow rate adapted during
anaesthesia to meet their individual requirements.
9.
ADVICE ON CORRECT ADMINISTRATION
In-circuit oxygen meters can be used to measure the inspired oxygen
fraction and depending on the
individual animal, a level of 50 – 100 % of the veterinary medicinal
product may be required. As a
rule, and if oxygen tension cannot be measured, the inspired oxygen
fraction should
                                
                                Read the complete document
                                
                            

Summary of Product characteristics

                                Medicinal product no longer authorised
ANNEX I
SUMMARY OF PRODUCT CHARACTERISTICS
1/15
Medicinal product no longer authorised
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Medicinal Oxygen Air Liquide Santé 100 % inhalation gas for dogs,
cats and horses.
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
ACTIVE SUBSTANCE:
100 % oxygen.
3.
PHARMACEUTICAL FORM
Inhalation gas.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Dogs, cats and horses.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For oxygen supplementation and as a carrier gas during inhalation
anaesthesia.
For oxygen supplementation during recovery.
4.3
CONTRAINDICATIONS
None.
4.4
SPECIAL WARNINGS 
None.
4.5
SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Oxygen in concentration up to 100 % (FiO
2
1.0) should not exceed 12 hours. Oxygen in concentration
over 80 % (FiO
2
0.8) should not exceed 18 hours.
Animals with pre-existing oxygen radical damage to the lung may have
this damage exacerbated by
oxygen therapy e.g. in the treatment of paraquat poisoning.
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE
VETERINARY MEDICINAL PRODUCT TO
ANIMALS
This veterinary medicinal product should only be used by persons who
have been fully trained to use
pressure regulators and associated equipment.
Whilst oxygen is non-flammable, it strongly supports combustion and no
naked flames should be
allowed near the container. Since even the smallest spark can cause
violent ignition, electrical
equipment capable of sparking should not be used in the vicinity of
patients receiving oxygen.
2/15
Medicinal product no longer authorised
Cylinder valves and associated equipment must not be lubricated and
must be kept entirely free from
carbon-based oils and grease because otherwise there is a risk of
spontaneous combustion and a
violent explosion may occur.
If you have been working in an oxygen-enriched atmosphere avoid
smoking, open flames or other
sources of ignition for at least 15 minutes
.
4.6
ADVERSE REACTIONS (FREQUENCY 
                                
                                Read the complete document
                                
                            

Documents in other languages

Patient Information leaflet Patient Information leaflet Bulgarian 12-01-2007
Summary of Product characteristics Summary of Product characteristics Bulgarian 12-01-2007
Public Assessment Report Public Assessment Report Bulgarian 12-01-2007
Patient Information leaflet Patient Information leaflet Spanish 12-01-2007
Public Assessment Report Public Assessment Report Spanish 12-01-2007
Patient Information leaflet Patient Information leaflet Czech 12-01-2007
Public Assessment Report Public Assessment Report Czech 12-01-2007
Patient Information leaflet Patient Information leaflet Danish 12-01-2007
Public Assessment Report Public Assessment Report Danish 12-01-2007
Patient Information leaflet Patient Information leaflet German 12-01-2007
Public Assessment Report Public Assessment Report German 12-01-2007
Patient Information leaflet Patient Information leaflet Estonian 12-01-2007
Public Assessment Report Public Assessment Report Estonian 12-01-2007
Patient Information leaflet Patient Information leaflet Greek 12-01-2007
Public Assessment Report Public Assessment Report Greek 12-01-2007
Patient Information leaflet Patient Information leaflet French 12-01-2007
Public Assessment Report Public Assessment Report French 12-01-2007
Patient Information leaflet Patient Information leaflet Italian 12-01-2007
Public Assessment Report Public Assessment Report Italian 12-01-2007
Patient Information leaflet Patient Information leaflet Latvian 12-01-2007
Public Assessment Report Public Assessment Report Latvian 12-01-2007
Patient Information leaflet Patient Information leaflet Lithuanian 12-01-2007
Summary of Product characteristics Summary of Product characteristics Lithuanian 12-01-2007
Public Assessment Report Public Assessment Report Lithuanian 12-01-2007
Patient Information leaflet Patient Information leaflet Hungarian 12-01-2007
Summary of Product characteristics Summary of Product characteristics Hungarian 12-01-2007
Public Assessment Report Public Assessment Report Hungarian 12-01-2007
Patient Information leaflet Patient Information leaflet Maltese 12-01-2007
Patient Information leaflet Patient Information leaflet Dutch 12-01-2007
Public Assessment Report Public Assessment Report Dutch 12-01-2007
Patient Information leaflet Patient Information leaflet Polish 12-01-2007
Public Assessment Report Public Assessment Report Polish 12-01-2007
Patient Information leaflet Patient Information leaflet Portuguese 12-01-2007
Summary of Product characteristics Summary of Product characteristics Portuguese 12-01-2007
Public Assessment Report Public Assessment Report Portuguese 12-01-2007
Patient Information leaflet Patient Information leaflet Romanian 12-01-2007
Public Assessment Report Public Assessment Report Romanian 12-01-2007
Patient Information leaflet Patient Information leaflet Slovak 12-01-2007
Public Assessment Report Public Assessment Report Slovak 12-01-2007
Patient Information leaflet Patient Information leaflet Slovenian 12-01-2007
Summary of Product characteristics Summary of Product characteristics Slovenian 12-01-2007
Public Assessment Report Public Assessment Report Slovenian 12-01-2007
Patient Information leaflet Patient Information leaflet Finnish 12-01-2007
Public Assessment Report Public Assessment Report Finnish 12-01-2007
Patient Information leaflet Patient Information leaflet Swedish 12-01-2007
Public Assessment Report Public Assessment Report Swedish 12-01-2007

Search alerts related to this product